Brain wave monitor may spot dialysis danger
NCT ID NCT03276273
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a device that measures brain waves (called BIS) can detect dialysis disequilibrium syndrome, a complication that can occur during first-time dialysis. Twenty new dialysis patients will be monitored during their first three sessions. The goal is to see if BIS readings change in a way that signals the condition, potentially offering a faster, more objective detection method than current clinical checks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a simple, objective way to detect a common complication of dialysis early.
- What could go wrong
- This is a very small, early study (20 people) looking at a monitoring device, not a treatment. It may not prove accurate enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dalian Medical University
RECRUITINGDalian, China
-
Theodor Bilharz Research Institute
RECRUITINGCairo, 8046, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug work safely in patients with kidney failure?
- What does life feel like for children with a rare birth defect? a new study asks
- AI therapy coach aims to ease distress in seriously ill seniors
- A simple stretch during dialysis might soothe restless legs
- A regenerative graft could rethink dialysis access
- Pumpkin seed oil may fight inflammation in kidney patients — a trial puts it to the test